IO Biotech, Inc. (IOBT)

USD 0.77

(0.84%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019
Revenue - - - - -
Cost of Revenue 756 Thousand 540 Thousand - - -
Gross Profit -756 Thousand -540 Thousand - - -
Operating Expenses 91.44 Million 71.42 Million 41.23 Million 10.14 Million 9.91 Million
Selling, General and Administrative Expenses 23.61 Million 24.43 Million 11.08 Million 1.68 Million 1.97 Million
Research and Development Expenses 67.82 Million 46.98 Million 30.15 Million 8.46 Million 7.93 Million
Other Expenses - - -26.53 Million -1.98 Million -781 Thousand
Cost and Expenses 91.44 Million 71.42 Million 41.23 Million 10.14 Million 9.91 Million
Operating Income -91.44 Million -71.42 Million -41.23 Million -10.14 Million -9.91 Million
Interest Expense - 302 Thousand 361 Thousand 26 Thousand 6000.00
Income Tax Expense 852 Thousand 1.27 Million 68 Thousand 26 Thousand 6000.00
Earnings before Tax -85.23 Million -70.18 Million -67.81 Million -12.04 Million -10.74 Million
Net Income -86.08 Million -71.45 Million -67.87 Million -12.06 Million -10.74 Million
Earnings Per Share Basic -1.98 -2.48 -2.36 -0.42 -0.37
Earnings Per Share Diluted -1.98 -2.48 -2.36 -0.42 -0.37
Weighted Average Shares Outstanding 43.53 Million 28.81 Million 28.81 Million 28.81 Million 28.81 Million
Weighted Average Shares Outstanding (Diluted) 43.53 Million 28.81 Million 28.81 Million 28.81 Million 28.81 Million
Gross Margin - - - - -
EBIT Margin - - - - -
Profit Margin - - - - -
EBITDA -91.22 Million -69.34 Million -67.45 Million - -824 Thousand
Earnings Before Tax Margin - - - - -

Income Statement Charts